Niagen Bioscience: A Breakout Quarter That Now Faces Its Biggest Market Shift In Years

Group 1 - Niagen Bioscience (NAGE) achieved a record quarter but faces increased competition in the NAD+ market [1] - The company is rated as a hold due to the competitive landscape [1] Group 2 - The analyst focuses on future-oriented industries, including digital assets and gaming publishers, which are reshaping global finance and entertainment [1] - The approach combines DCF and relative valuation with macro and narrative context to identify early positioning in leading companies and assets [1]